Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lin Y Chen

Showing results (101-110 of 184) with videos related to

Pageof 19
Sort By:
BMC Cardiovascular Disorders|September 7, 2017
Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillationFaye L Norby, Lindsay G S Bengtson, Pamela L Lutsey, et al.
Circulation. Arrhythmia and Electrophysiology|October 15, 2017
Association Between QT-Interval Components and Sudden Cardiac Death: The ARIC Study (Atherosclerosis Risk in Communities)Wesley T O'Neal, Matthew J Singleton, Jason D Roberts, et al.
The American Journal of Cardiology|December 12, 2018
Relation of the CHA<sub>2</sub>DS<sub>2</sub>-VASc Score to Risk of Thrombotic and Embolic Stroke in Community-Dwelling Individuals Without Atrial Fibrillation (From The Atherosclerosis Risk in Communities [ARIC] Study)Ryan J Koene, M Chadi Alraies, Faye L Norby, et al.
Journal of Clinical Gastroenterology|January 20, 2021
Proton Pump Inhibitor Use, Hypomagnesemia and Risk of Cardiovascular Diseases: The Atherosclerosis Risk in Communities (ARIC) StudyMary R Rooney, Elizabeth J Bell, Alvaro Alonso, et al.
Heart (British Cardiac Society)|November 21, 2014
Obesity related risk of sudden cardiac death in the atherosclerosis risk in communities studySelcuk Adabag, Rachel R Huxley, Faye L Lopez, et al.
Journal of the American Heart Association|September 20, 2014
Circulating fibroblast growth factor-23 and the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities studyAlvaro Alonso, Jeffrey R Misialek, John H Eckfeldt, et al.
Stroke|March 19, 2019
Association of Atrial Fibrillation With White Matter DiseaseIris Yuefan Shao, Melinda C Power, Thomas Mosley, et al.
Heart (British Cardiac Society)|March 8, 2020
Association of household income and adverse outcomes in patients with atrial fibrillationAnna Rose LaRosa, J'Neka Claxton, Wesley T O'Neal, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 6, 2016
Serum 25-hydroxyvitamin D and the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) studyAlvaro Alonso, Jeffrey R Misialek, Erin D Michos, et al.
Circulation|June 8, 2011
Chronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) studyAlvaro Alonso, Faye L Lopez, Kunihiro Matsushita, et al.
Pageof 19

Showing results (101-110 of 184) with videos related to

Sort By:
Pageof 19
BMC Cardiovascular Disorders|September 7, 2017
Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillationFaye L Norby, Lindsay G S Bengtson, Pamela L Lutsey, et al.
Circulation. Arrhythmia and Electrophysiology|October 15, 2017
Association Between QT-Interval Components and Sudden Cardiac Death: The ARIC Study (Atherosclerosis Risk in Communities)Wesley T O'Neal, Matthew J Singleton, Jason D Roberts, et al.
The American Journal of Cardiology|December 12, 2018
Relation of the CHA<sub>2</sub>DS<sub>2</sub>-VASc Score to Risk of Thrombotic and Embolic Stroke in Community-Dwelling Individuals Without Atrial Fibrillation (From The Atherosclerosis Risk in Communities [ARIC] Study)Ryan J Koene, M Chadi Alraies, Faye L Norby, et al.
Journal of Clinical Gastroenterology|January 20, 2021
Proton Pump Inhibitor Use, Hypomagnesemia and Risk of Cardiovascular Diseases: The Atherosclerosis Risk in Communities (ARIC) StudyMary R Rooney, Elizabeth J Bell, Alvaro Alonso, et al.
Heart (British Cardiac Society)|November 21, 2014
Obesity related risk of sudden cardiac death in the atherosclerosis risk in communities studySelcuk Adabag, Rachel R Huxley, Faye L Lopez, et al.
Journal of the American Heart Association|September 20, 2014
Circulating fibroblast growth factor-23 and the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities studyAlvaro Alonso, Jeffrey R Misialek, John H Eckfeldt, et al.
Stroke|March 19, 2019
Association of Atrial Fibrillation With White Matter DiseaseIris Yuefan Shao, Melinda C Power, Thomas Mosley, et al.
Heart (British Cardiac Society)|March 8, 2020
Association of household income and adverse outcomes in patients with atrial fibrillationAnna Rose LaRosa, J'Neka Claxton, Wesley T O'Neal, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 6, 2016
Serum 25-hydroxyvitamin D and the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) studyAlvaro Alonso, Jeffrey R Misialek, Erin D Michos, et al.
Circulation|June 8, 2011
Chronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) studyAlvaro Alonso, Faye L Lopez, Kunihiro Matsushita, et al.
Pageof 19